Commentary Open Access
Volume 1 | Issue 3 | DOI: https://doi.org/10.33696/Gastroenterology.1.012
Intestinal Barrier Function – a Novel Target to modulate Diet-induced Metabolic Diseases
Siddhartha S Ghosh1, Shobha Ghosh1,*
- 1Department of Internal Medicine, VCU Medical Center, Richmond, VA 23298, USA
Corresponding Author
Shobha Ghosh, shobha@vcu.edu
Received Date: July 10, 2020
Accepted Date: July 20, 2020
Ghosh SS, Ghosh S. Intestinal Barrier Function – a Novel Target to modulate Diet-induced Metabolic Diseases. Arch Gastroenterol Res. 2020; 1(3): 61-65.
Copyright: © 2020 Ghosh SS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Role of the Gut Microbiome in the Modulation of Cancer Immunotherapy Response
The gut microbiome or gut flora is a vast community of microorganisms such as bacteria, viruses, protozoa, and fungi that inhabit the digestive tract of the human and other animals [1,2]. In the human body, bacterial species colonize into the oral cavity, skin, vagina, and placenta, however, the largest population of microorganisms resides in the intestine.
Platelet Hyperactivity and Dysfunction in Diabetes and Cancer
However, the entire coagulation cascade is dysfunctional, in progressed chronic diabetes and cancer patients.
How Traditional Healers Diagnose and Treat Diabetes Mellitus in the Pretoria Mamelodi Area and How Do These Purported Medications Comply with Complementary and Alternative Medicine Regulations
CAM is widely used by patients to treat and prevent certain diseases, providing emotional and physical support [1]. The National Centre for Complementary and Alternative Medicine (NCCAM) defines CAM as a “group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine” [2].
Integrated Community Diabetes Model: Future of Diabetes Services and Way Forward?
Prevalence of diabetes is increasing. Diabetes is more prevalent in the socially deprived, ethnic minority population (based on continuing rise in elderly population, growing obesity and BME groups). Compliance is a major stumbling block in the management of most long-term conditions including diabetes.
The Profiling and Role of miRNAs in Diabetes Mellitus
Diabetes mellitus (DM) is an age-related metabolic disorder affecting 347 million people in modern society. Expanding its prevalence beyond developed countries, DM has emerged as a global public health issue associated with a high morbidity and mortality.